Vanflyta savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Vanflyta

We didn’t find one.

Ask your pharmacy for Vanflyta’s cash price, and one or two other pharmacies too.
Vanflyta’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify VANFLYTA Patient Assistance Program. Your annual income must be at or below a certain level Or call 1-866-437-4669.

See if you qualify

Compare every option

Brand nameVanflyta

Authorized genericquizartinib

Regular genericquizartinib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Vanflyta?

The original

–

Brand nameThe maker’s card

VANFLYTA Patient Savings Program (AccessCentral4U)

Savings card from Daiichi Sankyo

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

Or call 1-866-437-4669.

In the maker’s words

“Eligible patients may pay as little as $0 per prescription.”

From the maker’s offer on dsaccesscentral4u.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vanflyta itself, from the same company, sold without the brand name, and usually for less. For now Vanflyta is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Acute myeloid leukemia (AML) with FLT3-ITD

What the FDA label says

VANFLYTA is a kinase inhibitor indicated in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive as detected by an FDA-approved test.

Limitations of Use:

VANFLYTA is not indicated as maintenance monotherapy following allogeneic hematopoietic stem cell transplantation (HSCT); improvement in overall survival with VANFLYTA in this setting has not been demonstrated.

Source: the FDA label for Vanflyta (Daiichi Sankyo Inc.), April 16, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/vanflyta/